We are live on
!
Find out more
Glenview Capital Management Portfolio holdings
AUM
$5.49B
Turnover
46.55%
1-Year Est. Return
46.89%
This Fund
S&P 500
This Quarter
Est. Return
+10.52%
1 Year Est. Return
+46.89%
3 Year Est. Return
+94.27%
5 Year Est. Return
+129.04%
10 Year Est. Return
+529.98%
AUM
$14B
AUM Growth
+$2.09B
(+18%)
Cap. Flow
+$226M
Cap. Flow
% of AUM
1.62%
Top 10 Holdings %
Top 10 Hldgs %
40.13%
Holding
79
New
14
Increased
23
Reduced
18
Closed
12
Avg Time Held Equity + Options
0.4
years
Top 10 Avg Time Held Equity + Options
0.4
years
Top 20 Avg Time Held Equity + Options
0.4
years
Avg Time Held Equity only
0.4
years
Top 10 Avg Time Held Equity only
0.4
years
Top 20 Avg Time Held Equity only
0.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MON
Monsanto Co
MON
|
+$473M |
| 2 |
Tenet Healthcare
THC
|
+$166M |
| 3 |
Crown Castle
CCI
|
+$163M |
| 4 |
ADT Corp
ADT
|
+$126M |
| 5 |
AET
Aetna Inc
AET
|
+$118M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
McKesson
MCK
|
+$240M |
| 2 |
Xerox
XRX
|
+$173M |
| 3 |
Apple
AAPL
|
+$160M |
| 4 |
HSP
HOSPIRA INC
HSP
|
+$124M |
| 5 |
Microsoft
MSFT
|
+$123M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.44% |
| 2 | Technology | 11.02% |
| 3 | Consumer Discretionary | 9.01% |
| 4 | Communication Services | 8.63% |
| 5 | Industrials | 8.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Thermo Fisher Scientific
TMO
$249B
| $950M | 6.81% |
8,535,093
+451,432
| +6% | +$44.9M |
2013 Q2
2 quarters
|
|
2
HCA Healthcare
HCA
$102B
| $613M | 4.39% |
12,841,713
+2,500,000
| +24% | +$116M |
2013 Q2
2 quarters
|
|
|
3
Tenet Healthcare
THC
$21.9B
| $582M | 4.17% |
13,812,831
+3,813,492
| +38% | +$166M |
2013 Q2
2 quarters
|
|
|
MON
4
DELISTED
Monsanto Co
MON
| $580M | 4.15% |
4,973,530
+4,328,130
| +671% | +$473M |
2013 Q3
1 quarter
|
|
|
5
Crown Castle
CCI
$33.8B
| $575M | 4.12% |
7,825,290
+2,198,572
| +39% | +$163M |
2013 Q2
2 quarters
|
|
|
HMA
6
DELISTED
HEALTH MGMT ASSOC INC CL-A
HMA
| $495M | 3.54% |
37,757,583
| – | – |
2013 Q2
2 quarters
|
|
|
7
McKesson
MCK
$114B
| $492M | 3.53% |
3,050,925
-1,562,011
| -34% | -$240M |
2013 Q2
2 quarters
|
|
8
Flex
FLEX
$37.1B
| $468M | 3.35% |
79,860,133
+1,327,000
| +2% | +$8.06M |
2013 Q2
2 quarters
|
|
9
American International
AIG
$40.5B
| $440M | 3.15% |
8,620,064
| – | – |
2013 Q2
2 quarters
|
|
|
TWC
10
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
| $410M | 2.93% |
3,023,082
+698,966
| +30% | +$86.8M |
2013 Q2
2 quarters
|
|
11
Community Health Systems
CYH
$420M
| $372M | 2.66% |
11,461,931
+69,584
| +0.6% | +$2.39M |
2013 Q2
2 quarters
|
|
12
PVH
PVH
$3.76B
| $352M | 2.52% |
2,588,201
+825,000
| +47% | +$105M |
2013 Q2
2 quarters
|
|
13
Humana
HUM
$51.3B
| $345M | 2.47% |
3,340,499
-350,000
| -9% | -$34.3M |
2013 Q2
2 quarters
|
|
14
DELISTED
Walgreens Boots Alliance
WBA
| $342M | 2.45% |
5,951,526
-1,491,400
| -20% | -$86.8M |
2013 Q2
2 quarters
|
|
15
Pentair
PNR
$8.32B
| $303M | 2.17% |
5,805,388
-125,522
| -2% | -$5.84M |
2013 Q2
2 quarters
|
|
|
CSC
16
DELISTED
Computer Sciences
CSC
| $299M | 2.14% |
12,697,185
-2,896,059
| -19% | -$64.2M |
2013 Q2
2 quarters
|
|
17
DELISTED
Paramount Global Class B
PARA
| $284M | 2.03% |
4,449,502
| – | – |
2013 Q2
2 quarters
|
|
18
Fidelity National Information Services
FIS
$18.3B
| $267M | 1.92% |
4,982,585
-328,726
| -6% | -$16.2M |
2013 Q2
2 quarters
|
|
19
General Motors
GM
$72.9B
| $259M | 1.86% |
6,342,667
+550,000
| +9% | +$20.8M |
2013 Q2
2 quarters
|
|
20
Advance Auto Parts
AAP
$2.51B
| $256M | 1.84% |
2,317,353
-400,585
| -15% | -$39.8M |
2013 Q3
1 quarter
|
|
|
LPNT
21
DELISTED
LifePoint Health, Inc.
LPNT
| $242M | 1.73% |
4,580,637
+960,292
| +27% | +$48.2M |
2013 Q2
2 quarters
|
|
22
Cigna
CI
$76.5B
| $236M | 1.69% |
2,694,510
-85,100
| -3% | -$6.96M |
2013 Q2
2 quarters
|
|
23
PUT
3M
MMM
$84.8B
| $210M | 1.51% |
+1,794,000
| New | +$191M |
2013 Q4
0 quarters
|
|
24
DELISTED
LIFE TECHNOLOGIES CORP COM STK (DE)
LIFE
| $208M | 1.49% |
2,749,798
-1,501,326
| -35% | -$113M |
2013 Q2
2 quarters
|
|
|
25
DELISTED
ADT Corp
ADT
| $206M | 1.48% |
5,090,297
+3,065,845
| +151% | +$126M |
2013 Q3
1 quarter
|
|
Similar funds
MC
SCM
Glenview Capital Management's Q4 2013 Portfolio in Review
As of Q4 2013, Glenview Capital Management held 79 positions worth $14B, up 18% from $11.9B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Glenview Capital Management's Q4 2013 filing shows 14 new, 23 increased, 18 reduced and 12 closed positions. Its largest new stake was Aetna Inc: 1,815,441 shares worth $125M. The largest sale was McKesson, an estimated $240M.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 37% a quarter earlier, followed by Technology and Consumer Discretionary.
- Glenview Capital Management's largest Q4 2013 buy was Aetna Inc: 1,815,441 shares worth $125M.
- Glenview Capital Management added most to Monsanto Co in Q4 2013, an estimated $473M increase.
- Glenview Capital Management's biggest Q4 2013 reduction was McKesson, cutting an estimated $240M.
- Glenview Capital Management fully exited Apple in Q4 2013, selling an estimated $160M.
- Glenview Capital Management's ten largest holdings make up 40% of its $14B portfolio in Q4 2013.
- Glenview Capital Management opened 14 new positions and closed 12 in Q4 2013.
- Glenview Capital Management's portfolio value rose 18% quarter-over-quarter to $14B.
Based on Glenview Capital Management's 13F filing for Q4 2013, filed 14 Feb 2014.